Kinarus Therapeutics Holding AG / Key word(s): Annual Results Kinarus Therapeutics Group Reports 2022 Annual Results 31-May-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art. 53 LR The issuer is solely responsible for the content of this announcement. Ad hoc announcement pu.
Kinarus Therapeutics Holding AG / Key word(s): Annual Results Kinarus Therapeutics Group Reports 2022 Annual Results 31-May-2023 / 07:00 CET/CEST Release of an ad hoc announcement pursuant to Art.
The prevalence of idiopathic pulmonary fibrosis has been rising over the past few years, which prompts the growing demand for treatment options. The increasing prevalence of idiopathic pulmonary